Bellevue Group Ag Kymera Therapeutics, Inc. Transaction History

Bellevue Group Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$14.13 - $42.55 $740,412 - $2.23 Million	-52,400 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$35.3 - $64.68 $120,019 - $219,912	3,400 Added 6.94%	52,400 $2.22 Million
Q4 2021 Feb 10, 2022	BUY	$49.91 - $65.56 $673,785 - $885,060	13,500 Added 38.03%	49,000 $3.11 Million
Q3 2021 Nov 12, 2021	BUY	$47.8 - $66.66 $1.7 Million - $2.37 Million	35,500 New	35,500 $2.09 Million

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.23B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.